# ADR 515 — Enterprise Biotechnology Bio Marketplace Intelligence Platform (P217-P)

## Status

Accepted

## Context

P217-O established bio sustainability intelligence. P217-P defines Biotechnology Marketplace Intelligence: bio economy exchange, innovation marketplace, life science commercial intelligence, bio asset economy and scientific trust — before Bio Innovation Ecosystem (P217-Q).

## Decision

1. SoR remains `biotechnology` / `CAP-PLT-BIO-001` for marketplace *intelligence*.
2. Fabric: `meos_bio_marketplace_intelligence_fabric`.
3. API: `/api/v1/biotechnology/bio-marketplace*`.
4. Six marketplace layers; exchange, innovation, commercial intelligence, and bio asset economy platforms.
5. All inference via P214-Z ACL only — `no_module_local_llm`.
6. Human marketplace oversight and IP protection controls mandatory; never unverified scientific asset listing.
7. Therapeutic assets via P217-K; manufacturing via P217-L; supply via P217-M; regulatory via P217-N; sustainability via P217-O; robotics via P216-Z; quantum via P215-Z.
8. Never replace Core, AI, Quantum, Robotics, hospital EMR, LIMS, pharmacy, prior P217 fabrics including Bio Sustainability.
9. Foundation for P217-Q.

## Consequences

Positive: governed commercial intelligence layer for innovation-ecosystem and investment phases.  
Negative: IP / trust catalogs must stay aligned as autonomous bio economy systems deepen.

## Alternatives rejected

- Sibling `bio_marketplace` BC owning unrelated Core capabilities.
- Module-local LLM or listing scientific assets without verification.
- Merging peer SoRs (EMR/LIMS/pharmacy) into biotechnology without ACL peers.

## Related

Law: `ENTERPRISE_BIOTECHNOLOGY_BIO_MARKETPLACE.md` · Prior: ADR 499–514 · Next: P217-Q
